Ozempic Linked To Life-Threatening Side Effect
A potentially fatal side effect has been tied to the use of Ozempic and other GLP-1 drugs. Health officials in the United Kingdom have launched an investigation amid a rising number of GLP-1 drug users reportedly suffering problems related to their pancreas. In some cases, the issues have led to death. The U.K.’s Medicines and Healthcare […]
GLP1 secretagogue cinnamaldehyde upregulates GLP1/PI3K/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson’s disease
Publication date: August 2025 Source: International Journal of Biological Macromolecules, Volume 320, Part 1 Author(s): Kirti Mathur, Ritu Soni, Ruchi Yadav, Bhumika D. Patel, Jigna Shah
Four reasons why we shouldn’t always choose low-fat foods
It is something of a cliché that healthy eating advice can vary depending on the source. The clearest example may be recommendations about how much fat to have in your diet. For years, mainstream advice has been that we should reduce the amount of fat we eat, to aid weight control. We are supposed to […]
Not a One-Size-Fits-All Fix: What GLP-1 Success Depends On
Post Content
Eli Lilly (LLY) Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive – TipRanks
Eli Lilly (LLY) Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive TipRanks Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed AP News Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients CNN Opinion | The cruel costs of denying anti-obesity medication The Boston […]
How Food Manufacturers Can Meet the GLP-1 Moment
By Edward Fish, Senior Vice President and General Manager of Varietal Solutions at Bay State Milling Key takeaways: GLP-1 medications are reshaping consumer food behavior, with users seeking smaller, more nutrient-dense portions that support satiety, digestion, and overall wellness — driving a $190 billion market shift. Food manufacturers must reformulate products and innovate with functional […]
This FTSE 100 blue-chip could rise 26% in 12 months, according to brokers
To achieve a 26% return on any individual FTSE stock in a year would be a great outcome. Assuming the share was a fairly decent-sized holding, that gain could help power a market-beating portfolio performance. Diageo (LSE: DGE) could be one such stock, according to most analysts. Going on their consensus price target of 2,410p, […]
Oral Semaglutide: Will Injectors Switch?
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some fear misuse of oral agents. Medscape Medical News
A Dose Of Disruption: How Compounding Pharmacies Are Challenging Big Pharma On GLP-1 Drugs And Drug Patents
As demand for GLP-1 drugs grows, compounding pharmacies and telehealth startups are challenging Big Pharma’s grip on pricing, patents, and access to care.
Plus-size clothes are disappearing in the Ozempic era
Getty Images; Rebecca Zisser/BI Tess Holliday remembers 2019 as a “glorious” year for plus-size fashion and body positivity. The plus-size model and body activist walked the runway at New York Fashion Week. She’d been featured by magazines such as Cosmopolitan UK, Nylon, and Self. The cultural shift felt palpable — Rihanna’s Savage X Fenty runway […]